Abstract
Near-infrared (NIR) fluorescence imaging using exogenous fluorescent agents provides whole-field images in real-time to assist the surgeon in the excision of a tumor. Although the method has high sensitivity, the specificity can sometimes be lower than expected. Raman spectroscopy can detect tumors with high specificity. Therefore, a combination of both techniques can be advantageous. A complication that must be addressed is that the NIR spectral region is favored by both techniques for (in vivo) tissue analysis. When fluorescence and Raman emissions spectrally overlap, it becomes challenging or impossible to detect the Raman signal. In this paper, by avoiding this overlap, we describe a Raman spectroscopy setup capable of recording high-quality Raman spectra from tissue containing NIR exogenous fluorescent agents. We identify an optimal wavelength interval (900-915 nm) for Raman excitation, which avoids both excitation of fluorescent dyes and Raman signal self-absorption by the tissue. In this way, Raman spectroscopy can be combined with the currently most-used NIR fluorescent dyes. This combined novel setup could pave the way for clinical trials benefiting from both fluorescence imaging and Raman spectroscopy to avoid positive margins in cancer surgery.
Original language | English |
---|---|
Pages (from-to) | 2676-2682 |
Number of pages | 7 |
Journal | Analyst |
Volume | 148 |
Issue number | 12 |
Early online date | 18 Apr 2023 |
DOIs | |
Publication status | Published - 21 Jun 2023 |
Bibliographical note
Funding Information:The authors acknowledge the funding of Erasmus MC Foundation through Daniel den Hoed Award for young scientific talent. The authors also acknowledge SurgiMab S.A.S. for providing SGM-101 tracers. They would further like to thank Elisa M. Barroso, Yassine Aaboubout, Hidde A. Galema, Denise E. Hilling, Mahesh Algoe, Thierry van den Bosch, and Michail Doukas.
Publisher Copyright: © 2023 The Royal Society of Chemistry.